Y chromosome loss in male patients with primary biliary cirrhosis

Journal of Autoimmunity

Volumn 41, Issue , 2013, Pages 87-91

  Lleo, Ana ^a   Oertelt Prigione, Sabine ^b   Bianchi, Ilaria ^a   Caliari, Lisa ^a   Finelli, Palma ^c,d   Miozzo, Monica ^d,e   Lazzari, Roberta ^f   Floreani, Annarosa ^f   Donato, Francesca ^e   Colombo, Massimo ^e   Gershwin, M Eric ^g   Podda, Mauro ^a   Invernizzi, Pietro ^a,g  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Primary biliary cirrosis; Y chromosome

Indexed keywords

BILIRUBIN;

ADULT; AGED; ALLELE; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HAPLOINSUFFICIENCY; HUMAN; HUMAN TISSUE; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; Y CHROMOSOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; FEMALE; HAPLOINSUFFICIENCY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; SEX CHROMOSOME ABERRATIONS; SEX FACTORS;

EID: 84875965690     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.12.008     Document Type: Article

References (63)

1. Lleo A., Battezzati P.M., Selmi C., Gershwin M.E., Podda M. Is autoimmunity a matter of sex?. Autoimmunity Reviews 2008, 7:626-630.
2. Worthington J., Silman A.J. Genetic control of autoimmunity, lessons from twin studies. Clinical & Experimental Immunology 1995, 101:390-392.
3. Invernizzi P., Pasini S., Selmi C., Gershwin M.E., Podda M. Female predominance and X chromosome defects in autoimmune diseases. Journal of Autoimmunity 2009, 33:12-16.
4. Libert C., Dejager L., Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nature Reviews Immunology 2010, 10:594-604.
5. Invernizzi P., Miozzo M., Battezzati P.M., Bianchi I., Grati F.R., Simoni G., et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004, 363:533-535.
6. Invernizzi P., Miozzo M., Selmi C., Persani L., Battezzati P.M., Zuin M., et al. X chromosome monosomy: a common mechanism for autoimmune diseases. Journal of Immunology 2005, 175:575-578.
7. Miozzo M., Selmi C., Gentilin B., Grati F.R., Sirchia S., Oertelt S., et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology (Baltimore, Md) 2007, 46:456-462.
8. Sawalha A.H., Harley J.B., Scofield R.H. Autoimmunity and Klinefelter's syndrome: when men have two X chromosomes. Journal of Autoimmunity 2009, 33:31-34.
9. Stein C.M., Olson J.M., Gray-McGuire C., Bruner G.R., Harley J.B., Moser K.L. Increased prevalence of renal disease in systemic lupus erythematosus families with affected male relatives. Arthritis & Rheumatism 2002, 46:428-435.
10. Gonzalez D.A., Diaz B.B., Rodriguez Perez Mdel C., Hernandez A.G., Chico B.N., de Leon A.C. Sex hormones and autoimmunity. Immunology Letters 2010, 133:6-13.
11. Quintana-Murci L., Krausz C., McElreavey K. The human Y chromosome: function, evolution and disease. Forensic Science International 2001, 118:169-181.
12. Ali S., Hasnain S.E. Molecular dissection of the human Y-chromosome. Gene 2002, 283:1-10.
13. Jeong S.Y., Park S.J., Lee S.J., Park H.J., Kim H.J. Loss of Y chromosome in the malignant peripheral nerve sheet tumor of a patient with Neurofibromatosis type 1. Journal of Korean Medical Science 2010, 25:804-808.
14. Kirk J.A., VanDevanter D.R., Biberman J., Bryant E.M. Y chromosome loss in chronic myeloid leukemia detected in both normal and malignant cells by interphase fluorescence in situ hybridization. Genes, Chromosomes & Cancer 1994, 11:141-145.
15. Park S.J., Jeong S.Y., Kim H.J. Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array. Cancer Genetics and Cytogenetics 2006, 166:56-64.
16. Wallrapp C., Hahnel S., Boeck W., Soder A., Mincheva A., Lichter P., et al. Loss of the Y chromosome is a frequent chromosomal imbalance in pancreatic cancer and allows differentiation to chronic pancreatitis. International Journal of Cancer 2001, 91:340-344.
17. Wong A.K., Fang B., Zhang L., Guo X., Lee S., Schreck R. Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia/myelodysplastic syndrome?. Archives of Pathology & Laboratory Medicine 2008, 132:1329-1332.
18. Lippert E., Etienne G., Mozziconacci M.J., Laibe S., Gervais C., Girault S., et al. Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy. Haematologica 2010, 95:1604-1607.
19. Loss of the Y chromosome from normal and neoplastic bone marrows. United Kingdom Cancer Cytogenetics Group (UKCCG). Genes, Chromosomes & Cancer 1992, 5:83-88.
20. Kaplan M.M., Gershwin M.E. Primary biliary cirrhosis. New England Journal of Medicine 2005, 353:1261-1273.
21. Guttenbach M., Koschorz B., Bernthaler U., Grimm T., Schmid M. Sex chromosome loss and aging: in situ hybridization studies on human interphase nuclei. American Journal of Human Genetics 1995, 57:1143-1150.
22. Persani L., Bonomi M., Lleo A., Pasini S., Civardi F., Bianchi I., et al. Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis. Journal of Autoimmunity 2012, 38:J193-J196.
23. Invernizzi P., Pasini S., Selmi C., Miozzo M., Podda M. Skewing of X chromosome inactivation in autoimmunity. Autoimmunity 2008, 41:272-277.
24. Noelle R.J., Nowak E.C. Cellular sources and immune functions of interleukin-9. Nature Reviews Immunology 2010, 10:683-687.
25. Fawaz L.M., Sharif-Askari E., Hajoui O., Soussi-Gounni A., Hamid Q., Mazer B.D. Expression of IL-9 receptor alpha chain on human germinal center B cells modulates IgE secretion. Journal of Allergy and Clinical Immunology 2007, 120:1208-1215.
26. Chueh F.Y., Leong K.F., Cronk R.J., Venkitachalam S., Pabich S., Yu C.L. Nuclear localization of pyruvate dehydrogenase complex-E2 (PDC-E2), a mitochondrial enzyme, and its role in signal transducer and activator of transcription 5 (STAT5)-dependent gene transcription. Cellular Signalling 2011, 23:1170-1178.
27. Murphy E.D., Roths J.B. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis & Rheumatism 1979, 22:1188-1194.
28. Merino R., Fossati L., Lacour M., Izui S. Selective autoantibody production by Yaa+ B cells in autoimmune Yaa(+)-Yaa- bone marrow chimeric mice. The Journal of Experimental Medicine 1991, 174:1023-1029.
29. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:9970-9975.
30. Fairhurst A.M., Hwang S.H., Wang A., Tian X.H., Boudreaux C., Zhou X.J., et al. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. European Journal of Immunology 2008, 38:1971-1978.
31. Santiago-Raber M.L., Kikuchi S., Borel P., Uematsu S., Akira S., Kotzin B.L., et al. Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. Journal of Immunology 2008, 181:1556-1562.
32. Selmi C., Lu Q., Humble M.C. Heritability versus the role of the environment in autoimmunity. Journal of Autoimmunity 2012, 39:249-252.
33. Costenbader K.H., Gay S., Alarcon-Riquelme M.E., Iaccarino L., Doria A. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?. Autoimmunity Reviews 2012, 11:604-609.
34. Liu X., Invernizzi P., Lu Y., Kosoy R., Lu Y., Bianchi I., et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nature Genetics 2010, 42:658-660.
35. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Lu Y., et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. New England Journal of Medicine 2009, 360:2544-2555.
36. Mells G.F., Floyd J.A., Morley K.I., Cordell H.J., Franklin C.S., Shin S.Y., et al. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nature Genetics 2011, 43:329-332.
37. Selmi C., Mayo M.J., Bach N., Ishibashi H., Invernizzi P., Gish R.G., et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 2004, 127:485-492.
38. Moroni L., Bianchi I., Lleo A. Geoepidemiology, gender and autoimmune disease. Autoimmunity Reviews 2012, 11:A386-A392.
39. Chen R.C., Naiyanetr P., Shu S.A., Wang J., Yang G.X., Kenny T.P., et al. AMA heterogeneity and the xenobiotic etiology of primary biliary cirrhosis. Hepatology (Baltimore, Md) 2012.
40. Miller F.W., Pollard K.M., Parks C.G., Germolec D.R., Leung P.S., Selmi C., et al. Criteria for environmentally associated autoimmune diseases. Journal of Autoimmunity 2012, 39:253-258.
41. Miller F.W., Alfredsson L., Costenbader K.H., Kamen D.L., Nelson L.M., Norris J.M., et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. Journal of Autoimmunity 2012, 39:259-271.
42. Chang C., Gershwin M.E. Drug-induced lupus erythematosus: incidence, management and prevention. Drug Safety: An International Journal of Medical Toxicology and Drug Experience 2011, 34:357-374.
43. Gelpi E., de la Paz M.P., Terracini B., Abaitua I., de la Camara A.G., Kilbourne E.M., et al. The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge. Environmental Health Perspectives 2002, 110:457-464.
44. Hertzman P.A., Clauw D.J., Kaufman L.D., Varga J., Silver R.M., Thacker H.L., et al. The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. Annals of Internal Medicine 1995, 122:851-855.
45. Doyle H.A., Mamula M.J. Post-translational protein modifications in antigen recognition and autoimmunity. Trends in Immunology 2001, 22:443-449.
46. Doyle H.A., Mamula M.J. Autoantigenesis: the evolution of protein modifications in autoimmune disease. Current Opinion in Immunology 2012, 24:112-118.
47. Stea E.A., Routsias J.G., Samiotaki M., Panayotou G., Papalambros E., Moutsopoulos H.M., et al. Analysis of parotid glands of primary Sjogren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets. Clinical & Experimental Immunology 2007, 147:81-89.
48. Yang M.L., Gee A.J., Gee R.J., Zurita-Lopez C.I., Khare S., Clarke S.G., et al. Lupus autoimmunity altered by cellular methylation metabolism. Autoimmunity 2012.
49. Molberg O., McAdam S.N., Korner R., Quarsten H., Kristiansen C., Madsen L., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Medicine 1998, 4:713-717.
50. Lee T.P., Tang S.J., Wu M.F., Song Y.C., Yu C.L., Sun K.H. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes. Journal of Autoimmunity 2010, 35:358-367.
51. Lien E., Zipris D. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Current Molecular Medicine 2009, 9:52-68.
52. Shlomchik M.J. Sites and stages of autoreactive B cell activation and regulation. Immunity 2008, 28:18-28.
53. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
54. Lleo A., Selmi C., Invernizzi P., Podda M., Coppel R.L., Mackay I.R., et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (Baltimore, Md) 2009, 49:871-879.
55. Papini A.M. The use of post-translationally modified peptides for detection of biomarkers of immune-mediated diseases. Journal of Peptide Science: An Official Publication of the European Peptide Society 2009, 15:621-628.
56. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:10604-10609.
57. Javierre B.M., Fernandez A.F., Richter J., Al-Shahrour F., Martin-Subero J.I., Rodriguez-Ubreva J., et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Research 2010, 20:170-179.
58. Mitchell M.M., Lleo A., Zammataro L., Mayo M.J., Invernizzi P., Bach N., et al. Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis. Epigenetics: Official Journal of the DNA Methylation Society 2011, 6:95-102.
59. Selmi C., Feghali-Bostwick C.A., Lleo A., Lombardi S.A., De Santis M., Cavaciocchi F., et al. X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma. Clinical & Experimental Immunology 2012, 169:253-262.
60. Lin Q., Hou R., Sato A., Ohtsuji M., Ohtsuji N., Nishikawa K., et al. Inhibitory IgG Fc receptor promoter region polymorphism is a key genetic element for murine systemic lupus erythematosus. Journal of Autoimmunity 2010, 34:356-363.
61. Teuscher C., Noubade R., Spach K., McElvany B., Bunn J.Y., Fillmore P.D., et al. Evidence that the Y chromosome influences autoimmune disease in male and female mice. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:8024-8029.
62. Palaszynski K.M., Smith D.L., Kamrava S., Burgoyne P.S., Arnold A.P., Voskuhl R.R. A yin-yang effect between sex chromosome complement and sex hormones on the immune response. Endocrinology 2005, 146:3280-3285.
63. Spach K.M., Blake M., Bunn J.Y., McElvany B., Noubade R., Blankenhorn E.P., et al. Cutting edge: the Y chromosome controls the age-dependent experimental allergic encephalomyelitis sexual dimorphism in SJL/J mice. Journal of Immunology 2009, 182:1789-1793.